1. |
International Diabetes Federation. Diabetes Atlas (sixth edition). 2013.
|
2. |
杨昱, 王昆, 刘超.糖尿病基础胰岛素治疗.中国实用内科杂志, 2010, 30(10):939-941.
|
3. |
Ⅱag LL, Kerr L, Malone JK, et al. Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes:An Evident-based Comparison. Clin Ther, 2007, 29(6 pt1):1254-1270.
|
4. |
崔岱, 刘超.预混胰岛素在糖尿病治疗中的现状.国际内科学杂志, 2009, 36(1):19-22.
|
5. |
张兰, 欧阳晓波, 何继东.双相门冬胰岛素30每日3次注射治疗2型糖尿病的系统综述.中国循证医学杂志, 2012, 12(7):822-829.
|
6. |
Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes:a meta-analysis. Diabetes Res Clin Pract, 2008, 81(2):184-189.
|
7. |
Robbins DC, Beisswenger PJ, Ceriello A, et al. Mealtime 50/50 Basal + Prandial Insulin Analogue Mixture with a Basal Insulin Analogue, Both Plus Metformin, in the Achievement of Target HbA1c and Pre-and Postprandial Blood Glucose Levels in Patients with Type 2 Diabetes:A Multinational, 24-Week, Randomized, Open-Label, Parallel-Group Comparison. Clin Ther, 2007, 29(11):2349-2364.
|
8. |
Kazda C, Hülstrunk H, Helsberg K, et al. Prandial insulin substitution with insulin lispro vs. basal therapy with insulin glargine:A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy. J Diabetes Complications, 2006, 20(3):145-152.
|
9. |
Rosenstock J, Ahmann AJ, Colon G, et al. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents:prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy. Diabetes Care, 2008, 31(1):20-25.
|
10. |
Jain SM, Mao X, Escalante-Pulido M, et al. Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia:initiate and progressively advance insulin therapy in type 2 diabetes. Diabetes Obes and Metab, 2010, 12(11):967-975.
|
11. |
Buse JB, Wolffenbuttel BH, Herman WH, et al. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results:safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes. Diabetes Care, 2009, 32(6):1007-1013.
|
12. |
Eli L. Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Who Consume a Light Breakfast. ClinicalTrials.gov[serial online] 2011 Nov 9[cited 2013 Oct 24]. Available at: http://www.clinicaltrials.gov/ct2/show/results/NCT00664534?term=%E2%80%9Clispro%E2%80%9D+AND+%22glargine%22&rank=34§=Xd86015#outcome8.
|
13. |
陈立.甘精胰岛素联合格列美脲与优泌乐25治疗2型糖尿病的疗效比较.中国医学创新杂志, 2011, 8(16):126-127.
|
14. |
徐文明, 张常然, 崔卫玲, 等.甘精胰岛素联合那格列奈在继发性磺脲类失效的2型糖尿病中的应用.临床和实验医学杂志, 2012, 11(21):1705-1706.
|
15. |
王兴珍, 励丽, 毛洲宏, 等.甘精胰岛素联合瑞格列奈与预混胰岛素治疗的疗效与安全性比较.实用医学杂志, 2010, 26(16):3026-3028.
|
16. |
Jacober SJ, Scism-Bacon JL, Zagar AJ. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naive patients with type 2 diabetes receiving oral antidiabetes agents. Diabetes Obes Metab, 2006, 8(4):448-455.
|
17. |
Roach P, Malone JK. Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes. Diabet Med, 2006, 23(7):743-749.
|
18. |
Malone JK, Kerr LF, Campaigne BN, et al. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin:a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clin Ther, 2004, 26(12):2034-2044.
|
19. |
Malone JK, Bai S, Campaigne BN, et al. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes. Diabet Med, 2005, 22(4):374-381.
|
20. |
张天嵩, 钟文昭, 主编.实用循证医学方法学.第1版.长沙:中南大学出版社, 2012:148-159.
|
21. |
Elbourne DR, Altman DG, Higgins JP, et al. Meta-analyses involving cross-over trials:methodological issues. Int J Epidemiol, 2002, 31(1):140-149.
|
22. |
Farcasiu E, Ivanyi T, Mozejko-Pastewka B, et al. Efficacy and Safety of Prandial Premixed Therapy Using Insulin Lispro Mix 50/503 Times Daily Compared With Progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus:a randomized, 16-week, open-label study. Clin Ther, 2011, 33(11):1682-1693.
|